Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Rudy Saucillo who wrote (1449)	9/29/1998 3:27:00 PM
From: Steve Harmon	Read Replies (1) \| Respond to of 2742

Rudy, Agreed. And currently all of those indications have a premium of 0. Steve

To: Rudy Saucillo who wrote (1449)	9/30/1998 10:18:00 AM
From: Steve Harmon	Read Replies (2) \| Respond to of 2742

The good news is that the final details of the Bluestone Capital deal are now set. Bluestone REALLY wants the definitive deal with PMC to be signed.>>>>The price on the additional 400,000 warrants is now set at 25 cents. Cistron will be obligated to pay Bluestone 7% of any license fees or milestone payments PMC makes to Cistron. The agreement with Bluestone has expired as of this month(September). This finally frees Bluestone up to start giving Cistron some stock support.